Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether different doses of prophylactic platelet transfusions (platelet transfusions given to prevent bleeding) affect their efficacy and safety in preventing bleeding in patients with haematologi...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Estcourt, L, Stanworth, S, Doree, C, Trivella, M, Hopewell, S, Murphy, M, Tinmouth, A
Format:	Journal article
Język:	English
Wydane:	Wiley 2014

Podobne zapisy

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
od: Estcourt, L, i wsp.
Wydane: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Estcourt, L, i wsp.
Wydane: (2015)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
od: Estcourt, L, i wsp.
Wydane: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, i wsp.
Wydane: (2014)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, i wsp.
Wydane: (2014)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
od: Desborough, M, i wsp.
Wydane: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
od: Estcourt, L, i wsp.
Wydane: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, i wsp.
Wydane: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Crighton, GL, i wsp.
Wydane: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
od: Crighton, GL, i wsp.
Wydane: (2021)

Prophylactic platelet transfusions
od: Estcourt, L, i wsp.
Wydane: (2010)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, i wsp.
Wydane: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, i wsp.
Wydane: (2018)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Estcourt, L, i wsp.
Wydane: (2016)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
od: Stanworth, S, i wsp.
Wydane: (2004)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
od: Stanworth, S, i wsp.
Wydane: (2004)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
od: Desborough, M, i wsp.
Wydane: (2016)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Estcourt, L, i wsp.
Wydane: (2017)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review
od: Desborough, M, i wsp.
Wydane: (2016)

Pathogen-reduced platelets for the prevention of bleeding.
od: Butler, C, i wsp.
Wydane: (2013)

Platelet transfusions for patients with haematological malignancies: who needs them?
od: Estcourt, L, i wsp.
Wydane: (2011)

Pathogen-reduced platelets for the prevention of bleeding (Review)
od: Butler, C, i wsp.
Wydane: (2013)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
od: Huber, J, i wsp.
Wydane: (2019)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
od: Estcourt, L, i wsp.
Wydane: (2016)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
od: Estcourt, L
Wydane: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
od: Wardrop, D, i wsp.
Wydane: (2013)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
od: Huber, J, i wsp.
Wydane: (2018)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian translation of Cochrane plain language summary)
od: Desborough, MJR, i wsp.
Wydane: (2021)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia (Protocol)
od: Estcourt, L, i wsp.
Wydane: (2015)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
od: Stanworth, S, i wsp.
Wydane: (2014)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
od: Huber, J, i wsp.
Wydane: (2017)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
od: Wardrop, D, i wsp.
Wydane: (2016)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
od: Stanworth, S, i wsp.
Wydane: (2014)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
od: Butler, C, i wsp.
Wydane: (2011)

Alternatives to prophylactic platelet transfusions
od: Estcourt, L
Wydane: (2016)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia (Protocol)
od: Estcourt, L, i wsp.
Wydane: (2015)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
od: Estcourt, L, i wsp.
Wydane: (2016)

Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
od: Ashraf, A, i wsp.
Wydane: (2016)

Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
od: Estcourt, L, i wsp.
Wydane: (2016)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
od: Campbell, H, i wsp.
Wydane: (2014)